Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 325,892 | 32,948 | 0 | 0 | N/A |
| Marketable Securities | 144,559 | 187,711 | 0 | 0 | N/A |
| Receivables | 613 | 607 | 0 | 0 | N/A |
| TOTAL | $479,160 | $227,273 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 582 | 578 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,977 | 4,849 | 0 | 0 | 0 |
| TOTAL | $2,559 | $5,427 | $N/A | $N/A | $N/A |
| Total Assets | $481,719 | $232,700 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,041 | 4,899 | 0 | 0 | 0 |
| Accrued Expenses | 5,992 | 5,297 | 0 | 0 | N/A |
| TOTAL | $10,737 | $10,874 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,130 | 1,263 | 0 | 0 | 0 |
| TOTAL | $1,130 | $1,263 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,867 | $12,137 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,641 | 53,597 | N/A | N/A | N/A |
| Common Shares | 53 | 3 | 0 | 0 | N/A |
| Retained earnings | -190,780 | -169,538 | 0 | 0 | N/A |
| Other shareholders' equity | -25 | 381,225 | 0 | 0 | 0 |
| TOTAL | $469,852 | $220,563 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $481,719 | $232,700 | $0 | $0 | $0 |